Singapore markets close in 7 hours 2 minutes

Eupraxia Pharmaceuticals Inc. (EPRX.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
2.1000-0.0900 (-4.11%)
At close: 12:30PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
0
0
0
0
Operating expenses
Research development
7,651
859.781
2,942
6,645
Selling general and administrative
7,556
1,270
3,015
7,544
Total operating expenses
15,298
2,246
6,159
14,315
Operating income or loss
-15,298
-2,246
-6,159
-14,315
Interest expense
1,391
1,882
1,464
142.173
Total other income/expenses net
-3,076
116.761
369.698
-377.224
Income before tax
-19,732
-4,011
-7,241
-14,833
Income from continuing operations
-19,732
-4,011
-7,241
-14,833
Net income
-19,409
-3,997
-7,176
-13,232
Net income available to common shareholders
-19,409
-3,997
-7,176
-13,232
Basic EPS
-
-0.31
-0.56
-1.03
Diluted EPS
-
-0.31
-0.56
-1.03
Basic average shares
-
12,865
12,865
12,865
Diluted average shares
-
12,865
12,865
12,865
EBITDA
-
-2,012
-5,575
-14,565